BioSpace News Archive

Horizon Therapeutics plc Announces FDA Has Granted Priority Review of the Supplemental Biologics License Application (sBLA) for the Concomitant Use of KRYSTEXXA ® (pegloticase injection) Plus Methotrexate for People Living With Uncontrolled Gout.

Alpine Immune Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on its NEON-2 trial evaluating davoceticept.

Therapeutic Solutions International announced today data on what the Company believes to be a novel procedure to enhance anti-inflammatory and regenerative activity of all mesenchymal stem cells.

Moderna, Inc. announced that with the assistance of the U.S. Government, it has entered into a Memorandum of Understanding with the Government of the Republic of Kenya to establish Kenya as the location for the Company’s mRNA manufacturing facility.

OKYO Pharma Limited is pleased to announce that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its American Depositary Shares, each of which will represent one or a number of the Company’s ordinary shares of no par value each in the United States.

Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced the launch of the Clareon® family of intraocular lenses in the U.S. Utilizing Alcon’s most advanced IOL material, Clareon can deliver consistent visual outcomes and exceptional clarity that lasts.

The European Investment Bank has awarded a €7.5 million loan to Diadem Srl, a company developing the first blood-based prognostic test for the early prediction of Alzheimer’s disease.

Immunovia AB announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the patent application for the IMMray™ PanCan-d test available exclusively from Immunovia, Inc.

OMass Therapeutics announces the establishment of its scientific advisory board, comprising of world-renowned experts across biophysical technologies.

Veristat, a scientific-minded global clinical research organization, announced the expansion and strengthening of its service capabilities by acquiring SFL.